Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis
Journal of Bone and Mineral Metabolism2002Vol. 20(6), pp. 337–344
Citations Over TimeTop 11% of 2002 papers
Atsuko Mizuno, Takeshi Kanno, M. Hoshi, Osamu Shibata, Kazuki Yano, Nobuaki Fujise, Masahiko Kinosaki, Kyoji Yamaguchi, Toshio Suda, Akihiko Murakami, Hisataka Yasuda, Kanji Higashio
Related Papers
- → RANKL as the master regulator of osteoclast differentiation(2021)153 cited
- → An inhibitory role for caspase‐3 at the late stage of RANKL‐induced osteoclast differentiation in RAW264 cells and mouse bone marrow macrophages(2014)4 cited
- → The effects of tumor necrosis factor-α on osteoclast formation depend on the haematopoietic precursors(2006)
- 64Cu-RGD and microPET/CT as an imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation(2009)
- → Inhibitory Effect of Agrocybe Chaxingu (Chaxines) on RANKL-Induced Osteoclast Differentiation in RAW246.7 Cells: Possible Prevention of Osteoporosis(2022)